GRPM Among Mid Cap ETFs
End-of-day Nov 19, 2026 · 108 Mid cap ETFs by 1W
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.6% | −4.8% | −4.1% | −4.5% | +15.4% | +20.6% | +57.5% | +48.2% | +193.9% | +459.1% |
| Peer average | −1.8% | −4.4% | −4.0% | −7.3% | +7.8% | +13.1% | +48.4% | +32.3% | +178.4% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$34 of every $1,000 in GRPM is Abercrombie
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ANFAbercrombie & Fitch | Consumer Cyclical | 3.38% | $337.50 | 137K | $20.2M |
| 2 | DUOLDuolingo | Technology | 3.10% | $310.26 | 116K | $18.6M |
| 3 | SNSharkNinja | Consumer Cyclical | 2.93% | $292.51 | 76K | $17.5M |
| 4 | PCTYPaylocity | Technology | 2.70% | $269.98 | 92K | $16.1M |
| 5 | KNSLKinsale Capital Group | Financial Services | 2.58% | $258.48 | 39K | $15.5M |
| 6 | HALOHalozyme Therapeutics | Healthcare | 2.54% | $254.07 | 159K | $15.2M |
| 7 | RNRRenaissanceRe | Financial Services | 2.50% | $249.64 | 43K | $14.9M |
| 8 | APPFAppfolio | Technology | 2.45% | $245.02 | 70K | $14.7M |
| 9 | MEDPMedpace | Healthcare | 2.44% | $244.12 | 23K | $14.6M |
| 10 | EXELExelixis | Healthcare | 2.35% | $235.26 | 206K | $14.1M |
| 11 | DOCUDocusign | Technology | 2.30% | $230.29 | 180K | $13.8M |
| 12 | IDCCInterDigital | Technology | 2.29% | $228.59 | 49K | $13.7M |
| 13 | QLYSQualys | Technology | 2.27% | $226.91 | 69K | $13.6M |
| 14 | THCTenet Healthcare | Healthcare | 2.20% | $220.42 | 49K | $13.2M |
| 15 | MANHManhattan Associates | Technology | 2.15% | $215.13 | 51K | $12.9M |
of the $519B in 108 Mid cap ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ANF | Abercrombie & Fitch | 3.38% |
| 2 | DUOL | Duolingo | 3.10% |
| 3 | SN | SharkNinja | 2.93% |
| 4 | PCTY | Paylocity | 2.70% |
| 5 | KNSL | Kinsale Capital Group | 2.58% |
| 6 | HALO | Halozyme Therapeutics | 2.54% |
| 7 | RNR | RenaissanceRe | 2.50% |
| 8 | APPF | Appfolio | 2.45% |
| 9 | MEDP | Medpace | 2.44% |
| 10 | EXEL | Exelixis | 2.35% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.15 |
| Jun 22, 2026 | Jun 26, 2026 | $0.20 |
| Mar 23, 2026 | Mar 27, 2026 | $0.21 |
| Dec 22, 2025 | Dec 26, 2025 | $0.22 |
| Sep 22, 2025 | Sep 26, 2025 | $0.32 |
| Jun 23, 2025 | Jun 27, 2025 | $0.49 |
| Mar 24, 2025 | Mar 28, 2025 | $0.41 |
| Dec 23, 2024 | Dec 27, 2024 | $0.21 |
| Sep 23, 2024 | Sep 27, 2024 | $0.29 |
| Jun 24, 2024 | Jun 28, 2024 | $0.30 |
| Mar 18, 2024 | Mar 22, 2024 | $0.28 |
| Dec 18, 2023 | Dec 22, 2023 | $0.19 |